TherapeuticsMD, Inc. (TXMD) is a publicly traded Healthcare sector company. As of November 13, 2026, TXMD trades at $1.85 with a market cap of $21.07M and a P/E ratio of -100.00. TXMD moved +3.85% today. Year to date, TXMD is +2.22%; over the trailing twelve months it is +13.58%. Its 52-week range spans $0.83 to $2.95. Rallies surfaces TXMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for TXMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.85 |
| Market Cap | $21.07M |
| P/E Ratio | -100.00 |
| EPS | $-0.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.95 |
| 52-Week Low | $0.83 |
| Volume | 49.78K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.27M |
| Net Income | $-217.00K |
| Gross Margin | 0.00% |
TXMD analyst coverage data. Average price target: $0.00.